REPL logo

Replimune (REPL) Company Overview

Profile

Full Name:

Replimune Group, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 20, 2018

Indexes:

Not included

Description:

Replimune is a biotechnology company focused on developing innovative cancer therapies. They use a unique approach called oncolytic virus therapy, which targets and destroys cancer cells while sparing healthy tissue. Their goal is to improve treatment options for patients with various types of cancer.

Events Calendar

Earnings

Next earnings date:

May 16, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

May 16, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 JP Morgan
Overweight
Feb 13, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 22, 25 BMO Capital
Outperform
Dec 4, 24 Jefferies
Buy
Nov 22, 24 HC Wainwright & Co.
Buy
Nov 22, 24 BMO Capital
Outperform
Nov 12, 24 HC Wainwright & Co.
Buy
Sep 24, 24 JP Morgan
Overweight
Sep 16, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Replimune?
  • Does Replimune pay dividends?
  • What sector is Replimune in?
  • What industry is Replimune in?
  • What country is Replimune based in?
  • When did Replimune go public?
  • Is Replimune in the S&P 500?
  • Is Replimune in the NASDAQ 100?
  • Is Replimune in the Dow Jones?
  • When was Replimune's last earnings report?
  • When does Replimune report earnings?
  • Should I buy Replimune stock now?

What is the ticker symbol for Replimune?

The ticker symbol for Replimune is NASDAQ:REPL

Does Replimune pay dividends?

No, Replimune does not pay dividends

What sector is Replimune in?

Replimune is in the Healthcare sector

What industry is Replimune in?

Replimune is in the Biotechnology industry

What country is Replimune based in?

Replimune is headquartered in United States

When did Replimune go public?

Replimune's initial public offering (IPO) was on July 20, 2018

Is Replimune in the S&P 500?

No, Replimune is not included in the S&P 500 index

Is Replimune in the NASDAQ 100?

No, Replimune is not included in the NASDAQ 100 index

Is Replimune in the Dow Jones?

No, Replimune is not included in the Dow Jones index

When was Replimune's last earnings report?

Replimune's most recent earnings report was on Feb 12, 2025

When does Replimune report earnings?

The next expected earnings date for Replimune is May 16, 2025

Should I buy Replimune stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions